Remove 2025 Remove Drug Development Remove HIE
article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

In 2025, HealthTech valuations are expected to continue their upward trajectory, driven by several key factors: 1. Technological Advancements: AI and Machine Learning: AI-powered diagnostics, drug discovery, and personalised medicine are revolutionising healthcare.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.